ArticleScientific reports2025
The effects of triclabendazole, combined tetramisole with Oxyclozanide, and albendazole against ovine fasciolosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Targeting Leukopoiesis: Pharmacological and Biotechnological Strategies for the Treatment of Leukopenia.Biomedicines · 2026Review
- Colistin and Oxyclozanide co-loaded PLGA nano-microspheres to reverse colistin resistance can effectively treat colistin-resistantInternational journal of pharmaceutics: X · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent estimates suggest that liver condemnation due to liver fluke in Ethiopia causes an annual economic loss of about 48.4 million Ethiopian birr. For approximately ten decades, the treatment of fasciolosis has relied solely on triclabendazole (TCBZ). In many clinical practices, combined tetramisole with Oxyclozanide and albendazole drugs have been used as treatment options for ovine fasciolosis. Therefore, this study aimed to compare the effectiveness of triclabendazole (TCBZ), combined tetramisole with Oxyclozanide (TETRA), and albendazole (ALBE) for the treatment of ovine fasciolosis and their effects on biochemical parameters. In this study, a field experimental trial was carried out in 75 purposively selected forty-five naturally Fasciola-infected sheep from May to November 2023 in the West Dembiya district, Ethiopia. The infected animals were randomly divided into three Groups: Group I received triclabendazole, Group II received combined tetramisole with Oxyclozanide, Group III received albendazole, and the triclabendazole treatment Group was considered the positive control Group. Fecal and serum samples were collected on days 0 (before treatment) and 7, 14, and 21 after treatment. A fecal egg count reduction test (FECRT) and biochemical analysis were carried out. Descriptive statistics and repeated-measures ANOVA were used to analyze the data. The current study revealed that TCBZ was the most effective drug, with a FECRT of 97.8%, followed by TETRA (96.6%) and ALBE (84% reduction in the mean fecal egg count). The results also indicated that after treatment, the concentrations of the biochemical parameters significantly changed (P < 0.05), particularly after 21 days of treatment. In all the Groups, treatment and time had significant effects on the concentrations of the biochemical parameters and eggs per gram count (EPG). In terms of the EPG, albendazole substantially differed from combined tetramisole with Oxyclozanidee and triclabendazole (p < 0.05), whereas combined tetramisole with Oxyclozanide and triclabendazole did not (p > 0.05). The study also revealed that the observed clinical presentation improved after treatment. In conclusion, triclabendazole and combined tetramisole with Oxyclozanide strongly affected ovine fasciolosis. If the accessibility of triclabendazole is limited on the market, the use of the 2nd promising drug (combined tetramisole with Oxyclozanide) is mandatory. Biochemical parameters are the most promising biomarkers for liver damage and are used to select the most effective anthelmintic medicines for the treatment of ovine fasciolosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.